Iron/ethylcellulose (core/shell) nanoplatform loaded with 5-fluorouracil for cancer targeting

Colloids and Surfaces B: Biointerfaces

Volumn 77, Issue 1, 2010, Pages 111-116

  Arias, José L ^a   López Viota, Margarita ^a   Delgado, Ángel V ^b   Ruiz, M Adolfina ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

5 Fluorouracil; Drug targeting; Ethylcellulose; Iron; Magnetic core shell colloidal particles; Stimuli sensitive drug carriers

Indexed keywords

5-FLUOROURACIL; COLLOIDAL PARTICLE; CORE/SHELL; DRUG CARRIER; DRUG-TARGETING; ETHYLCELLULOSE; STIMULI-SENSITIVE;

ADSORPTION; ELECTROPHORETIC MOBILITY; EMULSIFICATION; MAGNETIC CIRCUITS; MAGNETIC MATERIALS; MEDICAL NANOTECHNOLOGY;

MAGNETISM;

ETHYL CELLULOSE; FLUOROURACIL; IRON; NANOCOMPOSITE; NANOSHELL;

ARTICLE; CANCER THERAPY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; DRUG RESPONSE; DRUG TARGETING; ELECTROPHORETIC MOBILITY; EVAPORATION; LOADING TEST; NANOEMULSION; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE PROPERTY;

ANTIMETABOLITES, ANTINEOPLASTIC; BIOCOMPATIBLE MATERIALS; CELLULOSE; DRUG DELIVERY SYSTEMS; FLUOROURACIL; IRON; NANOSTRUCTURES; NEOPLASMS;

EID: 77449156846     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.01.030     Document Type: Article

References (46)

1. Zhang N., Yin Y., Xu S.J., and Chen W.S. Molecules 13 (2008) 1551
2. Baccanari D.P., Davis S.T., Knick V.C., and Spector T. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 11064
3. Bertolini A., Fiumanò M., Muffatti A., Pedroncelli S., Doria A., Codazzi G., Giustiniani S., Scarinci A., and Redaelli G. Minerva Cardioangiol. 47 (1999) 269
4. Cooke J.W.B., Bright R., Coleman M.J., and Jenkins K.P. Org. Process Res. Dev. 5 (2001) 383
5. Maeda H. Adv. Enzyme Regul. 41 (2001) 189
6. Maeda H., Wu J., Sawa T., Matsumura Y., and Hori K. J. Controlled Release 65 (2000) 271
7. Moghimi S.M., Hunter A.C., and Murray J.C. Pharmacol. Rev. 53 (2001) 283
8. Arap W., Pasqualini R., and Ruoslahti E. Science 279 (1998) 377
9. Gabizon A., Shmeeda H., Horowitz A.T., and Zalipsky S. Adv. Drug Deliv. Rev. 56 (2004) 1177
10. Lu Y.J., and Low P.S. Adv. Drug Deliv. Rev. 54 (2002) 675
11. Park J.W., Hong K., Kirpotin D.B., Colbern G., Shalaby R., Baselga J., Shao Y., Nielsen U.B., Marks J.D., Moore D., Papahadjopoulus D., and Benz C.C. Clin. Cancer Res. 8 (2002) 1172
12. Meers P. Adv. Drug Deliv. Rev. 53 (2001) 265
13. Needham D., and Dewhirst M.W. Adv. Drug Deliv. Rev. 53 (2001) 285
14. Rapoport N. Int. J. Pharm. 277 (2004) 155
15. Shum P., Kim J.M., and Thompson D.H. Adv. Drug Deliv. Rev. 53 (2001) 273
16. Ulbrich K., and ŠubrF V. Adv. Drug Deliv. Rev. 56 (2004) 1023
17. Chua-anusorn W., Macey D.J., Webb J., de la Motte Hall P., and St Pierre T.G. Biometals 12 (1999) 103
18. Whittaker P., Ali S.F., Imam S.F., and Dunkel V.C. Regul. Toxicol. Pharmacol. 36 (2002) 280
19. Okon E., Pouliquen D., Okon P., Kovaleva Z.V., Stepanova T.P., Lavit S.G., Kudryavtsev B.N., and Jallet P. Lab. Invest. 71 (1994) 895
20. DeMerlis C.C., Schoneker D.R., and Borzelleca J.F. Food Chem. Toxicol. 43 (2005) 1355
21. Dubernet C., Rouland J.C., and Benoit J.P. Int. J. Pharm. 64 (1990) 99
22. Grattard N., Pernin M., Marty B., Roudaut G., Champion D., and LeMeste M. J. Controlled Release 84 (2002) 125
23. Kato T., Sato K., Sasaki R., Kakinuma H., and Moriyama M. Cancer Chemother. Pharmacol. 37 (1996) 289
24. Zinutti C., Kedzierewicz F., Hoffamn M., Benoit J.P., and Maincent P. Int. J. Pharm. 133 (1996) 97
25. Arias J.L., López-Viota M., López-Viota J., and Delgado A.V. Int. J. Pharm. 382 (2009) 270
26. Gupta A.K., and Gupta M. Biomaterials 26 (2005) 3995
27. Ibrahim A., Couvreur P., Roland M., and Speiser P. J. Pharm. Pharmacol. 35 (1983) 59
28. Lübbe A.S., Bergemann C., Riess H., Schriever F., Reichardt P., Possinger K., Matthias M., Doerken B., Herrmann F., Guertler R., Hohenberger P., Haas N., Sohr R., Sander B., Lemke A.J., Ohlendorf D., Huhnt W., and Huhn D. Cancer Res. 56 (1996) 4686
29. Lübbe A.S., Bergemann C., Huhnt W., Fricke T., Riess H., Brock J.W., and Huhn D. Cancer Res. 56 (1996) 4694
30. McCarron P.A., Woolfson A.D., and Keating S.M. J. Pharm. Pharmacol. 52 (2000) 1451
31. Arias J.L., Gallardo V., Ruiz M.A., and Delgado A.V. Eur. J. Pharm. Biopharm. 69 (2008) 54
32. Arias J.L., Linares-Molinero F., Gallardo V., and Delgado A.V. Eur. J. Pharm. Sci. 33 (2008) 252
33. Arias J.L., Gallardo V., Linares-Molinero F., and Delgado A.V. J. Colloid Interface Sci. 299 (2006)
34. Arias J.L., López-Viota M., Ruiz M.A., López-Viota J., and Delgado A.V. Int. J. Pharm. 339 (2007) 237
35. J.W. Vanderhoff, M.S. El-Aasser, J. Ugelstad, Polymer Emulsification Process. U.S. Patent No. 4,177,177, December 4, 1979.
36. Arias J.L., López-Viota M., Clares B., and Ruiz M.A. Eur. J. Pharm. Sci. 34 (2008) 257
37. Arias J.L., Harivardhan Reddy L., and Couvreur P. J. Drug Target. 17 (2009) 586
38. Greig N.H., Genka S., and Rapoport S.I. J. Controlled Release 11 (1990) 61
39. Novotný L., Farghali H., Janků I., and Beránek J. Cancer Chemother. Pharmacol. 24 (1989) 238
40. Arias J.L., Ruiz M.A., López-Viota M., and Delgado A.V. Colloids Surf., B: Biointerfaces 62 (2008) 64
41. Llovet M.I., Egea M.A., Valero J., Alsina M.A., García M.L., and Chauvet A. Drug Dev. Ind. Pharm. 21 (1995) 1761
42. Soppimath K.S., Aminabhavi T.M., Kulkarni A.R., and Rudzinski W.E. J. Controlled Release 70 (2001) 1
43. Stolnik S., Illum L., and Davis S.S. Adv. Drug Deliv. Rev. 16 (1995) 195
44. Brasseur N., Brault D., and Couvreur P. Int. J. Pharm. 70 (1991) 126
45. Satarkar N.S., and Hilt J.Z. J. Controlled Release 130 (2008) 246
46. Hu S.H., Liu T.Y., Liu D.M., and Chen S.Y. Macromolecules 40 (2007) 6786